Hopefully THC can be the leader and make it happen.

Cannabis oil firms chase approvals as over-the-counter sales are legalised

FreshLeaf Analytics, specialists in the Australian medicinal cannabis industry, said the first company to get its product on chemists’ shelves will have a significant advantage in a market estimated to exceed $200 million a year.

The Therapeutic Goods Administration (TGA) announced in December that it would “down-schedule” some low dose cannabidiol (CBD) preparations of up to 150 mg a day to allow pharmacists to dispense this medicine without a prescription.